New research tracks how cells prepare gene regulatory decisions that will define their fate during the earliest stages of ...

Inside the University of Miami’s newly opened 3D-bioprinting lab, the future of medicine looks a lot like science fiction.

"For the first time," Prasad wrote, "the US FDA will acknowledge that COVID-19 vaccines have killed American children." He ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BioNTech BNTX1.33%increase; green up pointing triangle plans to shrink its workforce and manufacturing network, as the German biotech company seeks to cut costs and downsize its footprint after demand ...

In an effort to reallocate resources to its growing oncology focus in the face of shrinking COVID-19 vaccine sales, German company BioNTech is slashing a large chunk of its manufacturing footprint, ...

The fight for two tumor types is poised to intensify, with BioNTech lining up a challenge to AstraZeneca, while SynOx Therapeutics is planning to enter a market served by companies including Daiichi ...

BioNTech reports a Q4 loss and issues disappointing guidance. BNTX shares crashed as cofounders announced plans of quitting. Here's why BioNTech stock is still worth buying on Tuesday. BioNTech ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — The co-founders of the ...

Feb 19 (Reuters) - German biopharmaceutical company BioNTech (22UAy.DE), opens new tab sued Moderna (MRNA.O), opens new tab in Delaware federal court on Thursday, alleging that Moderna's COVID-19 shot ...

BioNTech SE is flexible about its future structure as it prepares to bring a slew of cancer drugs to market, with its chief executive officer saying he would consider a deal with a partner that gets ...